Exact Sciences Statistics
Total Valuation
Exact Sciences has a market cap or net worth of $19.32 billion. The enterprise value is $20.85 billion.
Important Dates
The last earnings date was Monday, November 3, 2025, after market close.
| Earnings Date | Nov 3, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
Exact Sciences has 189.77 million shares outstanding. The number of shares has increased by 2.42% in one year.
| Current Share Class | 189.77M |
| Shares Outstanding | 189.77M |
| Shares Change (YoY) | +2.42% |
| Shares Change (QoQ) | +0.19% |
| Owned by Insiders (%) | 0.91% |
| Owned by Institutions (%) | 87.89% |
| Float | 187.94M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | 120.75 |
| PS Ratio | 6.20 |
| Forward PS | 5.31 |
| PB Ratio | 7.71 |
| P/TBV Ratio | n/a |
| P/FCF Ratio | 78.20 |
| P/OCF Ratio | 49.95 |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
The stock's EV/EBITDA ratio is 193.13, with an EV/FCF ratio of 84.40.
| EV / Earnings | n/a |
| EV / Sales | 6.77 |
| EV / EBITDA | 193.13 |
| EV / EBIT | n/a |
| EV / FCF | 84.40 |
Financial Position
The company has a current ratio of 2.72, with a Debt / Equity ratio of 1.01.
| Current Ratio | 2.72 |
| Quick Ratio | 2.30 |
| Debt / Equity | 1.01 |
| Debt / EBITDA | 17.25 |
| Debt / FCF | 10.26 |
| Interest Coverage | -3.82 |
Financial Efficiency
Return on equity (ROE) is -34.54% and return on invested capital (ROIC) is -1.25%.
| Return on Equity (ROE) | -34.54% |
| Return on Assets (ROA) | -1.09% |
| Return on Invested Capital (ROIC) | -1.25% |
| Return on Capital Employed (ROCE) | -2.08% |
| Revenue Per Employee | $440,290 |
| Profits Per Employee | -$140,940 |
| Employee Count | 7,000 |
| Asset Turnover | 0.49 |
| Inventory Turnover | 6.25 |
Taxes
| Income Tax | -8.19M |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +77.45% in the last 52 weeks. The beta is 1.42, so Exact Sciences's price volatility has been higher than the market average.
| Beta (5Y) | 1.42 |
| 52-Week Price Change | +77.45% |
| 50-Day Moving Average | 80.48 |
| 200-Day Moving Average | 57.71 |
| Relative Strength Index (RSI) | 87.43 |
| Average Volume (20 Days) | 7,214,265 |
Short Selling Information
The latest short interest is 5.10 million, so 2.69% of the outstanding shares have been sold short.
| Short Interest | 5.10M |
| Short Previous Month | 7.36M |
| Short % of Shares Out | 2.69% |
| Short % of Float | 2.71% |
| Short Ratio (days to cover) | 0.60 |
Income Statement
In the last 12 months, Exact Sciences had revenue of $3.08 billion and -$986.58 million in losses. Loss per share was -$5.26.
| Revenue | 3.08B |
| Gross Profit | 2.14B |
| Operating Income | -110.39M |
| Pretax Income | -994.77M |
| Net Income | -986.58M |
| EBITDA | 107.98M |
| EBIT | -110.39M |
| Loss Per Share | -$5.26 |
Full Income StatementBalance Sheet
The company has $1.00 billion in cash and $2.54 billion in debt, giving a net cash position of -$1.53 billion or -$8.07 per share.
| Cash & Cash Equivalents | 1.00B |
| Total Debt | 2.54B |
| Net Cash | -1.53B |
| Net Cash Per Share | -$8.07 |
| Equity (Book Value) | 2.50B |
| Book Value Per Share | 13.20 |
| Working Capital | 1.01B |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was $386.81 million and capital expenditures -$139.73 million, giving a free cash flow of $247.08 million.
| Operating Cash Flow | 386.81M |
| Capital Expenditures | -139.73M |
| Free Cash Flow | 247.08M |
| FCF Per Share | $1.30 |
Full Cash Flow StatementMargins
Gross margin is 69.42%, with operating and profit margins of -3.58% and -32.01%.
| Gross Margin | 69.42% |
| Operating Margin | -3.58% |
| Pretax Margin | -32.28% |
| Profit Margin | -32.01% |
| EBITDA Margin | 3.50% |
| EBIT Margin | -3.58% |
| FCF Margin | 8.02% |
Dividends & Yields
Exact Sciences does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -2.42% |
| Shareholder Yield | -2.42% |
| Earnings Yield | -5.11% |
| FCF Yield | 1.28% |
Dividend DetailsAnalyst Forecast
The average price target for Exact Sciences is $77.94, which is -23.45% lower than the current price. The consensus rating is "Buy".
| Price Target | $77.94 |
| Price Target Difference | -23.45% |
| Analyst Consensus | Buy |
| Analyst Count | 20 |
| Revenue Growth Forecast (5Y) | 9.53% |
| EPS Growth Forecast (5Y) | n/a |
Stock ForecastsFair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
Exact Sciences has an Altman Z-Score of 1.33 and a Piotroski F-Score of 5. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | 1.33 |
| Piotroski F-Score | 5 |
